We, at Bharat Cancer Hospital & Nirali Memorial radiation Center are committed to promote cancer related clinical research. We have created a support system with modern infrastructure to carry out drug trials. Our clinical research department is fully equipped with experienced & skilled staff. We conduct clinical trial ethically and abide by ICH-GCP and ICMR guidelines. We have large patient base who can be recruited for drug trials. The trials are carried out by experienced team of oncologist who are specialized in conducting retrospective & prospective studies.
CLINICAL STUDIES
| Phases of Clinical Trials | Therapeutic Area | Durations | Regulatory submission |
| IV | Advanced Breast Cancer (Stage III & IV) | June 2010 To June 2011 | DCGI |
| II | Metastatic Breast Cancer | May 2011 To Mar. 2012 | DCGI |
| BA/ BE | Metastatic Breast Cancer/ Metastatic Colorectal Cancer/ Duke’s C Colon Cancer | May 2011 To Aug. 2011 | Health Canada |
| BA/ BE | Metastatic Breast Cancer/ Metastatic Colorectal Cancer/ Duke’s C Colon Cancer | Aug. 2011 To Nov. 2011 | EMEA Europe |
| BA/ BE | Metastatic Breast Cancer/ Metastatic Colorectal Cancer/ Duke’s C Colon Cancer | Sept. 2011 To Mar. 2012 | US- FDA |
| III | Non Hodgkin’s Lymphoma | Sep. 2011 To Dec 2012 | DCGI |
| BA/ BE | Metastatic Breast Cancer/ Metastatic Colorectal Cancer/ Duke’s C Colon Cancer | Nov. 2011 To Mar. 2012 | EMEA- Europe & US- FDA |
| III | Non Myeloid Malignancies | Feb. 2012 To Aug 2012 | DCGI |
| BA/ BE | Metastatic Breast Cancer/ Metastatic Colorectal Cancer/ Duke’s C Colon Cancer | Feb. 2012 To Sep 2012 | ANVISA- Brazil |
| III | Advanced Follicular Lymphoma | Mar 2013 To Till date | DCGI |
| BA/ BE | Ovarian Cancer/ Pancreatic Cancer | Oct 2012 To Apr 2013 | US- FDA |
| II | Head & Neck Cancer | Jul 2012 To Till date | DCGI |
| BA/ BE | Glioblastoma Multiforme/ Anaplastic Astrocytoma | Jun 2012 To Dec 2012 | US- FDA |
| BA/ BE | Chronic Myeloid Leukemia | Nov 2012 To Apr 2013 | US- FDA |
CR STUDY
| indication | Phases of Trials | Duration | Regulatory Submission | Patient Recruitment Status |
| Non- Hodgkin’s Lymphoma | Serum Sample Collection Study | Dec 2012 till date | DCGI – India | Completed |
| Breast Cancer | III | Oct 2012 till date | US-FDA | Completed |
| Renal Cell Carcinoma | III | Sep 2012 till date | US-FDA | Completed |
| Metastatic Breast Cancer | III | Nov 2012 – Feb 2014 | US-FDA | Completed |
| Metastatic Breast Cancer | IV | Mar 2011- Oct 2013 | DCGI – India | Completed |
| Metastatic Prostate Cancer | IV | Mar 2011- Oct 2013 | DCGI – India | Completed |
TEAM OF ONCOLOGIST
| NAME & QUALIFICATION | EXPERTISE | Role in CLINICAL TRIALS |
| Dr. TANVEER M. MAKSUD MD-Medicine, ECMO. | Medical Oncologist | Investigator |
| Dr. NIKUNJ K. VITHLANI MS, DNB- Surgical Oncologist. | Surgical Oncologist | Investigator |
| Dr. NILESH MAHALE MD- Radiotherapy, PDCR. | Radiation Oncologist | Investigator |
ETHICS COMMITTEE
| Sl | Designation | Name & Qualification | Current position & mailing Address |
| 1 | Chairman | Dr. Neemesh Shivnath Verma , M.B.B.S, M.S (Gen) | Social Scientist |
| 2 | Member Secretary | Mr. Vinay Harishbhai Patel B.B.A,MBA-HR | Member Secretary, Asst. Manager |
| 3 | Advocate | Mr Samir Ramshankar Bajpai LLB, LLM. | Legal Expert |
| 4 | Layman | Mr Amitkumar Siyaram Yadav BA , MA. | |
| 5 | Basic Medical Scientist | Dr. Shailendra Kshamadhar Vajpeyee MBBS (MD- Pharmacology) | |
| 6 | Clinician | Dr. Mishal Jatin Shah MS, DNB Onco Surgery | |
| 7 | Social Scientist | Mr. Paresh Gunvantray Dave Sanskrit Sahitya Study of Karma (Theologian) | |
| 9 | EC Member | Ms Purvi Viraj Surve BA | |
| 10 | Scientific member | Dr Apexa Chandravadan Modi MBBS Diploma in Public Health | NA |
If you have any queries related to Clinical Trials, please visit our Hospital at the below address or call us on the number.
| Tel. | : +91 261 3088411 |
| Fax | : +91 261 2641004 |